TGF-β is not the principal immunosuppressive component in coagulation factor concentrates

British Journal of Haematology

Volumn 106, Issue 4, 1999, Pages 971-979

  Pearson, Helen J L ^a   Stirling, David ^a   Ludlam, Christopher A ^a   Steel, C Michael ^b  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF ST ANDREWS   (United Kingdom)

Author keywords

Coagulation factor; Haemophilia; Immuno suppression; Lymphocyte; TGF

Indexed keywords

BLOOD CLOTTING FACTOR; INTERLEUKIN 2; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CYTOKINE RELEASE; DISEASE MARKER; HEMOPHILIA; HUMAN; HUMAN CELL; IMMUNITY; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL;

ANIMALS; BLOOD COAGULATION FACTORS; CELL DIVISION; CELLS, CULTURED; HUMANS; IMMUNE TOLERANCE; LYMPHOCYTES; MICE; TRANSFORMING GROWTH FACTOR BETA;

EID: 0032828566     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01638.x     Document Type: Article

References (28)

1. Ahuja, S.S., Paliogianni, F., Yamada, H., Balow, J.E. & Boumpas, D.T. (1993) Effect of transforming growth factor-β on early and late activation events in human T cells. Journal of Immunology 150, 3109-3118.
2. Brown, P.D., Wakefield, L.M., Levinson, A.D. & Sporn, M.B. (1990) Physiochemical activation of recombinant latent transforming growth factor-betas 1, 2 and 3. Growth Factors, 3, 35-43.
3. De Biasi, R., Rocino, A., Miraglia, E., Mastrullo, L. & Quirino, A.A. (1991) The impact of very high purity factor VIII concentrate on the immune system of human immunodeficiency virus-infected hemophiliacs: a randomised prospective, two-year comparison with an intermediate purity concentrate. Blood, 78, 1919-1922.
4. European Pharmacopoeia (1971) Vol. II, p. 441.
5. Evans, J.A., Pasi, K.J. & Hill, F.H. (1995) Evidence for the actiological role of the blood-borne virus infections causing reduced lectin-induced T-cell proliferation in haemophiliac boys. British Journal of Haematology, 91, 197-202.
6. Fontana, A., Constam, D.B., Frei, K., Malipiero, U. & Pfister, H.W. (1992) Modulation of the immune response by transforming growth factor beta. International Archives of Allergy and Immunology, 99, 1-7.
7. Fox, F.E., Capocasale, R.J., Ford, H.C., Lamb, R.J., Moore, J.S. & Nowell, P.C. (1992) Transforming growth factor-β inhibits human T-cell proliferation through multiple targets. Lymphokine and Cytokine Research, 11, 299-305.
8. Froebel, K.S., Madhok, R., Forbes, C.D., Lennie, S.E., Lowe, G.D.O. & Sturrock, R.D. (1983) Immunological abnormalities in haemophilia: are they caused by American factor VIII concentrate? British Medical Journal, 287, 1091-1093.
9. Goedert, J.J., Kessler, C.M., Aledort, L.M., Biggar, R.J., Andes, W.A., White, G.C., Drummond, J.E., Vaidya, K., Mann, D.L., Eyster, M.E., Ragni, M.V., Lederman, M.M., Cohen, A.R., Bray, G.L., Rosenberg, P.S., Friedman, R.M., Hilgartner, M.W., Blattner, W.A., Kroner, B. & Gail, M.H. (1989) A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia. New England Journal of Medicine, 321, 1141-1148.
10. Hay, C.R.M. & McEvoy, P. (1989) The variable effect of diverse clotting factor concentrates on lymphocyte function in vitro. Thrombosis and Haemostasis, 62, 453.
11. Hay, C.R.M., Ludlam, C.A., Lowe, G.D.O., Mayne, E.E., Lee, R.J., Prescott, R.J. & Lee, C.A. (1998) The effect of monoclonal or ion-exchange purified factor VIII concentrate on HIV disease progression: a prospective cohort comparison. British Journal of Haematology, 101, 632-637.
12. Huang, S.S., O'Grady, P. & Huang, J.S. (1988) Human transforming growth factor β-aα2-macroglobulin complex is a latent form of transforming growth factor β. Journal of Biological Chemistry, 263, 1535-1541.
13. Lawrence, D.A., Pricher, R. & Jullien, P. (1985) Conversion of high molecular weight latent β-TGF from chicken embryo fibroblasts into a low molecular weight active β-TGF under acidic conditions. Biochemical and Biophysical Research Communications, 133, 1026-1034.
14. Lederman, M.M., Saunders, C., Toossi, Z., Lemion, N., Everson, B. & Ratnoff, O.D. (1986) Antihemophiliac factor (factor VIII) preparations inhibit lymphocyte proliferation and production of interleukin-2 secretion. Journal of laboratory and Clinical Medicine, 107, 471-478.
15. Like, B. & Massagué, J. (1986) The anti-proliferative effect of type β transforming, growth factor occurs at a level distal from receptors for growth-activating factors. Journal of Biological Chemistry, 261, 13426-13429.
16. Londei, M., Clayton, J. & Feldman, M. (1991) T cells and cytokines. Cytokines: a Practical Approach (ed. by F. R. Balkwill), pp. 155-156. Oxford University Press.
17. Loudon, W. & Grimm, E. (1991) The generation and quantitation of cell-mediated cytotoxicity. Cytokines: a Practical Approach (ed. by F. R. Balkwill). p. 173. Oxford University Press.
18. McDonald, C., Jackson, V., Kilpatrick, D.C., Yap, P.L. & Prowse, C. (1985) A diffusable factor on Scottish coagulation factor concentrates can inhibit lymphocyte transformation in vitro. Vox Sanguinis, 49, 187-194.
19. Meager, A. (1991) Assays for transforming growth factor β. Journal of Immunological Methods, 141, 1-14.
20. Miyazono, K., Yuki, K., Takaku, F., Wernstedt, C., Kanzaki, T., Olofsson, A., Hellman, U. & Heldin, C.-H. (1990) Latent forms of TGF-β: structure and biology. Annals of the New York Academy of Sciences, 593, 51-58.
21. O'Connor-McCourt, M. & Wakefield, L.M. (1987) Latent transforming growth factor-β in serum. Journal of Biological Chemistry, 262, 14090-14099.
22. Pasi, K.J., Evans, J.A., Wadhwa, M., Thorpe, R. & Hill, F.G.H. (1995) Association of changes in monocyte antigen presentation and cytokine production in haemophiliac boys with treatment und blood-borne virus infection. British Journal of Haematology, 91, 191-196.
23. R, a monoclonal antibody purified human plasma factor VIII:C therapeutic preparation. Thrombosis and Haemostasis, 58, 346.
24. Schulman, S. (1991) Effects of factor VIII concentrates on the immune system in haemophiliac patients. Annals of Haematology, 63, 145-151.
25. Thorpe, R., Dilger, P., Dawson, N.J. & Barroweliffe, T.W. (1989) Inhibition of interleukin-2 secretion by factor VIII concentrates: a possible cause of immunosuppression in haemophiliacs, British Journal of Haematology, 71, 387-391.
26. Wadhwa, M., Dilger, P., Tubbs, J., Barowcliffe, T., Mahon, B. & Thorpe, R. (1992) Mechanisms of inhibition of T cell II.-2 secretion by factor VIII concentrates. British Journal of Haematology, 82, 575-583.
27. Wadhwa, M., Dilger, P., Tubbs, J., Mire-Sluis, A., Barowcliffe, T. & Thorpe, R. (1994) Identification of transforming growth factor-β as a contaminant in factor VIII concentrates: a possible link with immunosuppressive effects in hemophiliacs. Blood, 84, 2021-2030.
28. Wakefield, L.M., Smith, D.M., Flanders, K. & Sporn, M.B. (1988) Latent transforming growth factor-β from human platelets. Journal of Biological Chemistry 263, 7646-7654.